Cargando…
Designing of CD8(+) and CD8(+)-overlapped CD4(+) epitope vaccine by targeting late and early proteins of human papillomavirus
BACKGROUND AND AIM: Human papillomavirus (HPV) is an oncogenic agent that causes over 90% of cases of cervical cancer in the world. Currently available prophylactic vaccines are type specific and have less therapeutic efficiency. Therefore, we aimed to predict the potential species-specific and ther...
Autores principales: | Kaliamurthi, Satyavani, Selvaraj, Gurudeeban, Kaushik, Aman Chandra, Gu, Ke-Ren, Wei, Dong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174296/ https://www.ncbi.nlm.nih.gov/pubmed/30323556 http://dx.doi.org/10.2147/BTT.S177901 |
Ejemplares similares
-
Integrated PPI- and WGCNA-Retrieval of Hub Gene Signatures Shared Between Barrett's Esophagus and Esophageal Adenocarcinoma
por: Nangraj, Asma Sindhoo, et al.
Publicado: (2020) -
Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches
por: Selvaraj, Gurudeeban, et al.
Publicado: (2021) -
Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights
por: Selvaraj, Gurudeeban, et al.
Publicado: (2021) -
Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19
por: Kaliamurthi, Satyavani, et al.
Publicado: (2021) -
Exploring the Papillomaviral Proteome to Identify Potential Candidates for a Chimeric Vaccine against Cervix Papilloma Using Immunomics and Computational Structural Vaccinology
por: Kaliamurthi, Satyavani, et al.
Publicado: (2019)